South Korea - Healthcare, Regulatory and Reimbursement Landscape

Lowest Prices Guaranteed	Length	Publisher	Published Date	SKU
from $1,995	184 Pages	GlobalData	December, 2021	GBDT16946574

Lowest Prices Guaranteed
Price	from $1,995
Length	184 Pages
Publisher	GlobalData
Published Date	December, 2021
SKU	GBDT16946574

South Korea - Healthcare, Regulatory and Reimbursement Landscape

Summary

GlobalData, the industry analysis specialist, has released its latest report: “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - South Korea”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in South Korea. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

South Korea’s pharmaceutical market has high potential and is one of the fastest developing pharmaceutical markets in Asia. The rise in communicable and non-communicable diseases, and government initiatives such as National Drug Policy intended to drive the growth of the South Korean pharmaceutical market. While inadequate power and water supply, dysfunctional transport system, and under-utilized manufacturing capacity, along with counterfeiting drugs are hindering the development of the healthcare market. South Korea’s pharmaceutical market, based on pharmaceutical production value, was $20.6B in 2013 and is expected to increase to $27.9B in 2020 at a Compound Annual Growth Rate (CAGR) of 4.4%. It is forecast to reach about $36.9B in 2026. The medical devices market of South Korea was valued at $7.8B in 2016, which is expected to increase to $9.9B in 2020 at a CAGR of 5.9%. The medical device market is expected to grow at a CAGR of 4.5% from $10.9B in 2021 to $14.4B in 2027.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in South Korea, and includes -

An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers.
Profiles and SWOT analyses of the major players in the pharmaceutical market: Novartis, GlaxoSmithKline, Pfizer, Chon Kun Dang, and Celltrion.
Profiles and SWOT analyses of the major players in the medical device market: Abbott, Medtronic, GE Healthcare, Canon and i-sens.
An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices.
Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure.
An overview of the opportunities for and challenges to growth in the South Korea’s healthcare Market

Reasons to Buy

This report will enhance your decision-making capability by allowing you to -

Develop business strategies by understanding the trends shaping and driving South Korean healthcare market
Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact South Korean healthcare market in the future
Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

1 Table of Contents: 1.1 List of Figures; 1.2 List of Tables
2 Executive Summary: 2.1 Executive Summary; 2.2 Key Highlights - Facts about the South Korea Healthcare Market; 2.3 Key Highlights: Healthcare Startups in South Korea; 2.4 Key Events: South Korea Pharmaceutical News, 2015-2021; 2.5 Key Events: South Korea Pharmaceutical Market; 2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2020-2021; 2.7 Key Events: Mergers and Acquisitions; 2.8 Country Profile, South Korea, 2021
3 Overview of Pharmaceutical Market: 3.1 Pharmaceutical Market - Overview; 3.2 Pharmaceutical Market - Exports; 3.3 Pharmaceutical Market - Imports; 3.4 Pharmaceutical Market - Supply Channels, South Korea; 3.5 Pharmaceutical Market - Market Segments; 3.6 COVID-19 Epidemiology, South Korea; 3.7 COVID-19 Impact and Developments in the Healthcare Market, South Korea; 3.9 Pharmaceutical Market - Major Players
4 Overview of Medical Devices Market: 4.1 Medical Device Market - Overview; 4.2 Medical Devices Market - Major Players
5 Pharmaceutical and Medical Devices Market - Drivers and Barriers: 5.1 Drivers; 5.2 Barriers
6 Deal Analysis: 6.1 Deal Analysis: Pharmaceutical Market, South Korea, 2019-2021; 6.2 Deal Analysis: Medical Device Market, South Korea, 2019-2021
7 HealthTech Landscape: 7.1 HealthTech Landscape, South Korea; 7.2 HealthTech Deals Landscape, South Korea; 7.3 Adoption of Technology in Healthcare, South Korea; 7.4 Key HealthTech Deals, South Korea; 7.5 Digital Statistics, South Korea; 7.6 HealthTech Landscape, South Korea; 7.7 Digital Regulations, South Korea; 7.8 COVID-19 Impact on Digital Health, South Korea; 7.9 HealthTech Landscape: Benefits and Risks, South Korea
8 Market Access: 8.1 Overview of Healthcare System, South Korea; 8.2 Reimbursement Process, South Korea; 8.3 Overview of Insurance Providers, Public Insurance, South Korea; 8.4 Out-of-Pocket Spending and Pharmaceutical Price Index, South Korea; 8.5 Pricing Policies, South Korea; 8.6 Regulatory Landscape, South Korea; 8.6.1 Marketing Authorization for Pharmaceutical Products, South Korea; 8.6.2 Marketing Authorization for Generic Medicines, South Korea; 8.6.3 Marketing Authorization for OTC, South Korea; 8.6.4 Marketing Authorization for Biologics and Biosimilars, South Korea; 8.6.5 Pharmaceutical Market - Drug Approvals; 8.6.6 Marketing Authorization for Medical Devices, South Korea; 8.6.7 Pharmaceutical Export and Import, South Korea; 8.6.8 Intellectual Property Rights, South Korea; 8.6.9 Intellectual Property Rights, Patent, South Korea; 8.6.10 Intellectual Property Rights, Trademark, South Korea; 8.6.11 Clinical Trial Regulation Process, South Korea; 8.6.12 Pharmaceutical Clinical Trials Landscape, South Korea; 8.6.13 Medical Device Clinical Trials Landscape, South Korea; 8.6.14 Pharmaceutical Advertising Regulations, South Korea; 8.6.15 Pharmacy Regulations, South Korea; 8.6.16 Labeling and Packaging Regulations, South Korea; 9. Country Healthcare Landscape; 9.1 South Korean Healthcare Policy Highlights; 9.2 Healthcare Facilities, South Korea; 9.3 Life Expectancy and Immunization Rate, South Korea; 9.4 Environmental Health, South Korea; 9.5 Healthcare Personnel, South Korea; 9.6 Disease Burden, South Korea; 9.7 Healthcare Expenditure, South Korea
10 Trade Associations, South Korea
11 Trade Fairs, South Korea
12 Opportunities and Challenges
13 Appendix: 13.1 Research Methodology; 13.1.1 Coverage; 13.1.2 Secondary Research; 13.1.3 Forecasts; 13.2 Bibliography; 13.3 About GlobalData; 13.4 Contact Us; 13.5 Disclaimer
List of Tables: Table 1: Approved Biosimilars, South Korea, 2020; Table 2: Key Approved Biologics, South Korea, 2020-2021; Table 3: Top 5 Imported Products, OTC Market ($M), South Korea, 2020; Table 4: COVID-19 Indicators, Global and South Korea, 2020-2021; Table 5: COVID-19-Related Travel Restrictions, South Korea, 2020-2021; Table 6: Authorized COVID-19 Vaccines, South Korea, 2020-2021; Table 7: Available COVID-19 IVD Products, South Korea, 2020-2021; Table 8: Pipeline COVID-19 IVD Products, South Korea, 2020-2021; Table 9: Medical Devices Market, South Korea, Major Segments ($M), 2020; Table 10: Hospital Supplies Market, South Korea, Revenue ($M) and Market Share (%) of Major Companies, 2020; Table 11: General Surgery Market, South Korea, Revenue ($M) and Market Share (%) of Major Companies, 2020; Table 12: Dental Devices, South Korea, Revenue ($M) and Market Share (%) of Major Companies, 2020; Table 13: Cardiovascular Devices, South Korea, Revenue ($M) and Market Share (%) of Major Companies, 2020; Table 14: Orthopedic Devices, South Korea, Revenue ($M) and Market Share (%) of Major Companies, 2020; Table 15: Insurance Contribution Rates, South Korea, 2021; Table 16: Co-payment Ceiling System, South Korea, 2021; Table 17: National Long-Term Care Insurance System vs. Previous Elderly Benefit Service System, South Korea, 2021; Table 18: Pricing by Drug Type, South Korea, 2018; Table 19: OTC Monograph Therapeutic Categories, South Korea, 2021; Table 20: MFDA Gap Analysis of Biosimilar Guidelines for the Extrapolation of Indications, South Korea, 2021; Table 21: Medical Devices Classification, South Korea, 2021; Table 22: Patent Fees, South Korea, 2021; Table 23: Trademark Application Fee, South Korea, 2021; Table 24: Drug Container and Package Information, South Korea, 2021; Table 25: Package Insert Information, South Korea, 2021; Table 26: Conferences and Trade Fairs, South Korea
List of Figures: Figure 1: Pharmaceutical Market, South Korea, Revenue ($B and KRWM), 2013-2020; Figure 2: Medical Devices Market, South Korea, Revenue ($M), 2016-2021; Figure 3: Healthcare Start-Ups in South Korea, 2021; Figure 4: Country Profile, South Korea, 2021; Figure 5: Pharmaceutical Market, South Korea, Revenue ($B), 2013-2020; Figure 6: Pharmaceutical Market, South Korea, Revenue Forecast ($B), 2021-2026; Figure 7: Pharmaceutical Exports ($B), South Korea, 2011-2020; Figure 8: Top Export Partners, South Korea, 2020; Figure 9: Pharmaceutical Imports ($B), South Korea, 2011-2020; Figure 10: Top Import Partners, South Korea, 2020; Figure 11: Process of Assigning the Korea Drug Code, South Korea, 2021; Figure 12: Drug Supply and Reporting Process of Drug Transaction Records, South Korea, 2021; Figure 13: Major Bio-health Clusters, South Korea, 2021; Figure 14: Number of Biosimilar and Biologics Drug Approvals, South Korea, 2016-2020; Figure 15: Top Biopharma Companies (by Sales, $M), South Korea, Jan 2021-Jun 2021; Figure 16: Patent Expirations of Major Biologics, South Korea, 2021; Figure 17: OTC Medicines Market, (per Capita Expenditure [$B]), South Korea, 2010-2020; Figure 18: OTC Medicines Market, Market Value ($M), South Korea, 2012-2020; Figure 19: OTC Medicines Market, Major Market Value Segmentation (%), South Korea, 2019; Figure 20: Therapeutic Area by Sales per Capita ($/person), South Korea, 2019; Figure 21: Therapeutic Area by Pharmaceutical Consumption (DDD/1,000 person/day), South Korea, 2018; Figure 22: COVID-19 (Number of Deaths), South Korea, 2020-2021; Figure 23: COVID-19 (Number of Cases), South Korea, 2020-2021; Figure 24: COVID-19 Fiscal Stimulus Timeline, South Korea, 2020-2021; Figure 25: COVID-19 Vaccine Dose Administration, Number of Vaccine Doses Administered, South Korea, 2021; Figure 26: COVID-19 Clinical Trials Sponsors by Count, South Korea, 2020-2021; Figure 27: COVID-19 Clinical Trials Count by Phase, South Korea, 2020-2021; Figure 28: COVID-19 Clinical Trials Count by Trial Status, South Korea, 2020-2021; Figure 29: Medical Devices Market, South Korea, Revenue ($B), 2016-2020; Figure 30: Medical Devices Market, South Korea, Revenue Forecast ($B), 2021-2026; Figure 31: Medical Devices Market, South Korea, Major Segments (%), 2020; Figure 32: Hospital Supplies Market, South Korea, Revenue ($M), 2016-2024; Figure 33: Hospital Supplies Market, South Korea, Market Share of Major Players (%), 2020; Figure 34: General Surgery Market, South Korea, Revenue ($M), 2016-2023; Figure 35: General Surgery Market, South Korea, Market Share of Major Players (%), 2020; Figure 36: Dental Devices, South Korea, Revenue ($M), 2016-2023; Figure 37: Dental Devices, South Korea, Market Share of Major Players (%), 2020; Figure 38: Cardiovascular Devices, South Korea, Revenue ($M), 2016-2023; Figure 39: Cardiovascular Devices, South Korea, Market Share of Major Players (%), 2020; Figure 40: Orthopedic Devices, South Korea, Revenue ($M), 2016-2023; Figure 41: Orthopedic Devices, South Korea, Market Share of Major Players (%), 2020; Figure 42: Diagnostic Market, South Korea, Revenue ($M), 2016-2021; Figure 43: Diagnostic Market, South Korea, Revenue ($M), 2022-2027; Figure 44: Deals Value and Deal Count, Pharmaceutical Market, South Korea, 2019-2021; Figure 45: Deals Value and Deal Count Subtypes, Pharmaceutical Market, South Korea, 2019-2021; Figure 46: Deals Value and Deal Count, Quarterly, Pharmaceutical Market, South Korea, 2019-2021; Figure 47: Top Therapy Areas by Deal Value ($M), Pharmaceutical Market, South Korea, 2019-2021; Figure 48: M&A Deals by Quarter, Pharmaceutical Market, South Korea, 2019-2021 (by Value and by Number); Figure 49: Top Therapy Areas by Deal Count, Pharmaceutical Market, South Korea, 2019-2021; Figure 50: Private Equity Deals by Quarter, Pharmaceutical Market, South Korea, 2019-2021 (by Value and by Number); Figure 51: Deals Value and Deal Count, Medical Devices Market, South Korea, 2019-2021; Figure 52: Deals Value and Deal Count Subtypes, Medical Devices Market, South Korea, 2019-2021; Figure 53: Deals Value and Deal Count, Quarterly, Medical Devices Market, South Korea, 2019-2021; Figure 54: Top Equipment Sectors by Deal Value ($M), Medical Devices Market, South Korea, 2019-2021; Figure 55: M&A Deals by Quarter, Medical Devices Market, South Korea, 2019-2021 (by Value and by Number); Figure 56: Top Equipment Sectors by Deal Count, Medical Devices Market, South Korea, 2019-2021; Figure 57: VF Deals by Quarter, Medical Devices Market, South Korea, 2019-2021 (by Value and by Number); Figure 58: Deals Value ($M), HealthTech, South Korea, 2019-2021; Figure 59: Deal Count (Number of Deals), HealthTech, South Korea, 2019-2021; Figure 60: Digital Statistics, South Korea; Figure 61: Key Goals: Digital New Deal, South Korea, 2021; Figure 62: Key Policy Highlights: Digital New Deal, South Korea, 2021